Introduction Semaglutide has emerged as a groundbreaking treatment option for those struggling with type 2 diabetes, obesity, and cardiovascular risk. As part of the GLP-1 receptor agonist class, Semaglutide mimics the actions of a naturally occurring hormone in the body, glucagon-like peptide-1 (GLP-1), which plays a vital role in regulating https://eduardomgvlz.wikibriefing.com/2999722/semaglutide_a_breakthrough_in_managing_type_2_diabetes_obesity_and_heart_health